SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lövgren Tanja 1976 )
 

Sökning: WFRF:(Lövgren Tanja 1976 ) > Single-Cell RNA Ana...

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

Sarén, Tina (författare)
Uppsala universitet,Cancerimmunterapi,Science for Life Laboratory, SciLifeLab,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
Ramachandran, Mohanraj, 1988- (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi,Vaskulärbiologi,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
Gammelgård, Gustav (författare)
Uppsala universitet,Cancerimmunterapi,Science for Life Laboratory, SciLifeLab,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
visa fler...
Lövgren, Tanja (författare)
Uppsala universitet,Cancerimmunterapi,Science for Life Laboratory, SciLifeLab,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
Mirabello, Claudio, 1984- (författare)
Linköpings universitet,Bioinformatik,Tekniska fakulteten,Linköping University
Björklund, Åsa, 1976 (författare)
Chalmers University of Technology, Sweden,Chalmers tekniska högskola
Wikström, Kristina (författare)
VECURA, Karolinska University Hospital, Sweden,Karolinska universitetssjukhuset,Karolinska University Hospital
Hashemi, Jamileh (författare)
Uppsala universitet,Cancerimmunterapi,Science for Life Laboratory, SciLifeLab,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
Freyhult, Eva, 1979- (författare)
Uppsala universitet,Cancerfarmakologi och beräkningsmedicin,Uppsala University, Sweden
Ahlström, Håkan, 1953- (författare)
Uppsala universitet,Institutionen för kirurgiska vetenskaper,Antaros Medical AB, Mölndal, Sweden,Radiologisk bildanalys,Uppsala University, Uppsala, Sweden; Antaros Medical AB, Sweden
Amini, Rose-Marie (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
Hagberg, Hans (författare)
Uppsala universitet,Cancerimmunterapi,Science for Life Laboratory, SciLifeLab,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
Loskog, Angelica, 1973- (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden; Lokon Pharma AB, Uppsala, Sweden,Uppsala University
Enblad, Gunilla (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
Essand, Magnus (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi,Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden,Uppsala University
visa färre...
 (creator_code:org_t)
American Association for Cancer Research Inc. 2023
2023
Engelska.
Ingår i: Clinical Cancer Research. - : American Association for Cancer Research Inc.. - 1078-0432 .- 1557-3265. ; 29:20, s. 4139-4152
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Purpose: Although CD19 chimeric antigen receptor T cells (CAR-T) therapy has shown remarkable success in B-cell malignancies, a substantial fraction of patients do not obtain a long-term clinical response. This could be influenced by the quality of the individual CAR-T infusion product. To shed some light on this, clinical outcome was correlated to characteristics of CAR-T infusion products. Patients and Methods: In this phase II study, patients with B-cell lymphoma (n ¼ 23) or leukemia (n ¼ 1) received one or two infusions of third-generation CD19-directed CAR-Ts (2 × 108/m2). The clinical trial was registered at clinicaltrials. gov: NCT03068416. We investigated the transcriptional profile of individual CD19 CAR-T infusion products using targeted single-cell RNA sequencing and multicolor flow cytometry. Results: Two CAR-T infusions were not better than one in the settings used in this study. As for the CAR-T infusion products, we found that effector-like CD8þCAR-Ts with a high polyfunctionality, high cytotoxic and cytokine production profile, and low dysfunctional signature were associated with clinical response. An extended ex vivo expansion time during CAR-T manufacturing negatively influenced the proportion of effector CD8þCAR-Ts in the infusion product. Conclusions: We identified cell-intrinsic characteristics of effector CD8þCAR-Ts correlating with response that could be used as an indicator for clinical outcome. The results in the study also serve as a guide to CAR-T manufacturing practices. ©2023 The Authors; Published by the American Association for Cancer Research.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

CD19 antigen; CD27 antigen; interleukin 2 receptor alpha; antigen expression; Article; B cell lymphoma; CD8+ T lymphocyte; cell subpopulation; chimeric antigen receptor immunotherapy; clinical article; clinical feature; clinical outcome; cohort analysis; controlled study; correlational study; cytokine production; cytotoxicity; disease association; ex vivo study; flow cytometry; gene cluster; genetic transcription; human; human cell; leukemia; phase 2 clinical trial; phenotype; RNA analysis; single cell analysis; treatment indication

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy